Global Next Generation Sequencing Data Analysis Market, By Product (Service, NGS Commercial Software and Others), Workflow (Primary Data Analysis, Secondary Data Analysis and Tertiary Data Analysis), Mode (In-house Data Analysis and Outsourced Data Analysis), Read Length (Long Read Sequencing, Short Read Sequencing, Very long Read Sequencing), End-Use (Academic Research, Clinical Research, Hospitals and Clinics, Pharma and Biotech Entities and Others) – Industry Trends and Forecast to 2030.
Next Generation Sequencing Data Analysis Market Analysis and Size
The Undiagnosed Diseases Program (UDN), an NHGRI initiative, uses DNA sequencing to discover the causes of rare diseases. While the National Cancer Institute and NHGRI collaborate on the Cancer Genome Atlas project, which uses DNA sequencing to study the genomic patterns of 30 cancer types. Ongoing and planned projects in genome sequencing are expected to drive the market for next-generation sequencing data analysis.
Data Bridge Market Research analyses that the next generation sequencing data analysis market which is USD 778.46 million in 2022, is expected to reach USD 2677.94 million by 2030, at a CAGR of 16.7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Next Generation Sequencing Data Analysis Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Million, Volumes in Units, Pricing in USD
Product (Service, NGS Commercial Software and Others), Workflow (Primary Data Analysis, Secondary Data Analysis and Tertiary Data Analysis), Mode (In-house Data Analysis and Outsourced Data Analysis), Read Length (Long Read Sequencing, Short Read Sequencing, Very long Read Sequencing), End-Use (Academic Research, Clinical Research, Hospitals and Clinics, Pharma and Biotech Entities and Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Thermo Fisher Scientific, Inc. (U.S.), QIAGEN (Germany), Illumina, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Pierian (India), Precigen (Germany), Partek Incorporated (U.S.), Eurofins Scientific (Luxembourg), PacBio (U.S.), DNASTAR (U.S.), Congenica Ltd. (U.K.), Fabric Genomics, Inc. (U.S.), DNAnexus Inc. (U.S.)
NGS, also known as high throughput sequencing, is a term that refers to a number of advanced sequencing technologies. Researchers can investigate biological processes in depth for next-generation sequencing's high throughput, scalability, and speed. A higher level of understanding than that provided by traditional DNA sequencing methods is now required because of the complexities involved in genomic science.
Global Next Generation Sequencing Data Analysis Market Dynamics
- Rising research and development activities
Globally, major corporations have increased their capacity for research and development. During the pandemic, the heavy emphasis on COVID-19 vaccine development provided a lucrative opportunity for NGS adoption. For instance, a group of Chinese researchers sequenced COVID-19 samples using the Oxford Nanopore Technologies (UK) product MinION Mk1C. Furthermore, factors such as widespread adoption of NGS technologies in clinical diagnostics due to faster results and processing are expected to provide a favourable environment for market growth during the forecast period.
- Rise in use of clinical diagnosis
The advancement of next-generation sequencing (NGS) technologies and their increasing use in clinical diagnosis, genomic research, and personalised medicine for a variety of diseases is increasing the demand for accurate and fast sequencing interpretation tools and algorithms that can speed up data analysis. Furthermore, as the amount of genetic data produced grows and sequencing costs fall, the size of sequencing projects is expected to grow. As a result, there is a greater demand for complex bioinformatics pipelines with cutting-edge, effective solutions.
- Technological advancements
Growing technological advances in NGS instruments and technologies are expected to drive significant market growth in the coming years. For instance, the Intelligence Advanced Research Projects Activity in the United States awarded a USD 23 million grant to Harvard University, DNA Script, and the Broad Institute in January 2020. The institutes are working together to create a new technology that will combine enzymatic DNA synthesis and NGS into a single instrument.
- High cost
The cost of infrastructural development for algorithms and software is expected to limit market growth to some extent. In the forecast period, a lack of skilled personnel will act as a restraint, further challenging the growth of the next generation sequencing data analysis market.
Furthermore, the time-consuming nature of NGS data analysis is impeding market growth.
This next generation sequencing data analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the next generation sequencing data analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Next Generation Sequencing Data Analysis Market
COVID-19 began to spread throughout the world in early 2020, infecting millions of people. Major nations around the world have now endorsed restrictions and work stoppage orders. With the exception of those manufacturing medical supplies and life support equipment, the majority of businesses have suffered significant damage. Next-generation sequencing data analysis industries have also been severely impacted. As a result of the COVID-19 outbreak, NGS usage has skyrocketed, and there is now a sizable market for NGS data analysis tools. The NGS technologies were able to generate a large amount of data for the purpose of studying and analysing pathogenesis. Sequencing has been used by experts from academia, business, and government to aid in the study of SARS-CoV2 traits, procedures, and phylogenetics.
- In 2021, Cerba Research announced the launch of new tools to improve R&D for vaccine development against infectious diseases, including COVID-19.
- In 2021, Swift Biosciences, a pioneer in the development of NGS library preparation genomics kits for clinical, translational, and academic research, was acquired by Integrated DNA Technologies (IDT).
Global Next Generation Sequencing Data Analysis Market Scope
The next generation sequencing data analysis market is segmented on the basis of product, workflow, mode, read length and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- NGS Commercial Software
- Platform OS/UI
- Analytical Software
- QC/Pre-processing Tools
- Alignment Tools and Software
- DNA Seq Alignment
- RNA Seq Alignment
- Protein Seq Alignment
- Read Mapping
- Variant Alignment and Variant Calling
- Variant Annotation
- Application Specific
- Targeted Sequencing/Gene Panel
- RNA Seq
- Whole Genome
- Chip Seq
- Long Read Sequencing
- Short Read Sequencing
- Very long Read Sequencing
- Academic Research
- Clinical Research
- Hospitals and Clinics
- Pharma and Biotech Entities
- Other Users
Next Generation Sequencing Data Analysis Market Regional Analysis/Insights
The next generation sequencing data analysis market is analysed and market size insights and trends are provided by country, product, workflow, mode, read length and end-user as referenced above.
The countries covered in the next generation sequencing data analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the next generation sequencing data analysis market owing to technological advancements in sequencing platforms and rise in applications of NGS in this region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the increasing number of grants received for sequencing projects in this region's developing countries.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The next generation sequencing data analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for next generation sequencing data analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the next generation sequencing data analysis market. The data is available for historic period 2011-2021.
Competitive Landscape and Next Generation Sequencing Data Analysis Market Share Analysis
The next generation sequencing data analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to next generation sequencing data analysis market.
Some of the major players operating in the next generation sequencing data analysis market are:
- Thermo Fisher Scientific, Inc. (U.S.)
- QIAGEN (Germany)
- Illumina, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Agilent Technologies, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Pierian (India)
- Precigen (Germany)
- Partek Incorporated (U.S.)
- Eurofins Scientific (Luxembourg)
- PacBio (U.S.)
- DNASTAR (U.S.)
- Congenica Ltd. (U.K.)
- Fabric Genomics, Inc. (U.S)
- DNAnexus Inc. (U.S.)